r.rotation.to⌕ Search stocks, people, sectors
Following this device: dark.
Request a free account

Follow the people · Insider

MA

Mark Alvino

Insider · Director · ABEO

Mark Alvino files insider transactions with the SEC as a director of Abeona Therapeutics (ABEO). We hold 4 disclosed purchases and sales filed since 8 December 2006, 1 of them in the last 90 days.

  • Files forABEO
  • Disclosed buys and sells4 in all, 1 in the last 90 days
  • Last disclosure1 September 2026

Positions held

5 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 11 May 2015 — 1 September 2026Director · Abeona Therapeutics (ABEO)34 Form 4 lines · source: SEC Form 4
  • Filed 11 May 2015 — 11 May 2015Director · Plasmatech Biopharmaceuticals (PTBI)2 Form 4 lines · source: SEC Form 4
  • Filed 7 March 2014 — 7 March 2014Director · Access Pharmaceuticals (accp)2 Form 4 lines · source: SEC Form 4
  • Filed 5 September 2007 — 10 October 2007Director · Macrochem (MACM)2 Form 4 lines · source: SEC Form 4
  • Filed 6 December 2006 — 6 December 2006Director · Access Pharmaceuticals (ACCP.OB)1 Form 4 line · source: SEC Form 4

Everything they disclosed

41 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.